KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.3880
+0.0080 (2.11%)
At close: Mar 2, 2026, 4:00 PM EST
0.3920
+0.0040 (1.03%)
After-hours: Mar 2, 2026, 6:07 PM EST
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$943,184
Market Cap
10.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | 188 | 52 | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 25 |
| Longeveron | 25 |
| SeaStar Medical Holding | 19 |
| Soligenix | 16 |
| BioVie | 13 |
| Akari Therapeutics, | 9 |
| Pulmatrix | 2 |
KALA News
- 2 months ago - KALA BIO Settles Approximately $10.6 million of Debt - GlobeNewsWire
- 3 months ago - KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Why Is Eye Disease Focused Kala Bio Stock Plunging On Monday? - Benzinga
- 7 months ago - KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 8 months ago - KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) - GlobeNewsWire
- 9 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Announces Chief Executive Officer Transition - GlobeNewsWire